Evidence map›Paper›PMID 40721906›Full record

ReviewJournal of assisted reproduction and genetics2025

Oocyte cryopreservation for fertility preservation in transgender and gender diverse individuals: a SWOT analysis.

Julia E Barbe, Federico Del Vento, Dehlia Moussaoui, Victoria L Crofts, Michal Yaron, Isabelle Streuli

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia E BarbeDivision of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland. julia.barbe@hug.ch.ORCID http://orcid.org/0009-0003-1544-6275
Federico Del VentoDivision of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland.
Dehlia MoussaouiDivision of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland.
Victoria L CroftsDivision of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland.
Michal YaronDivision of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland.
Isabelle StreuliDivision of Gynecology, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine of Geneva, Geneva University Hospitals, Geneva, 1205, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gender affirming hormone therapy may be used to relieve dysphoria among transgender or gender-diverse individuals. However, the long-term effects of these treatments on reproductive health remain uncertain. Before initiating hormone therapy, it is essential that patients are fully informed about the potential impact on their reproductive capabilities. Fertility preservation options, such as oocyte cryopreservation, should be offered to gender diverse individuals who were assigned female at birth. To assist healthcare providers in navigating the complexities of fertility preservation for these patients, we conducted a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis focused of oocyte cryopreservation. This analysis aims to ensure that decisions are both clinically sound and aligned with the patient's reproductive goals.

Indexed as

CryopreservationFertility PreservationOocytesTransgender PersonsFemaleHumansMaleFertility preservationOocyte cryopreservationSWOT analysisTransgender and gender diverse individualsTransgender health

Identifiers

PMID40721906
PMCPMC12559567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.